Navigation Links
Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses

Researchers from Max Plank Institute of Developmental Biology have uncovered some of the molecular mysteries associated with synaptic connections between the neurons, that represent the structural and functional unit of the brain. //

In simple terms, the junction between two neurons is referred to as a synapse. It serves as a gateway of communication between the same. Storage and transmission of information occurs through these specialized contact sites. This synaptic connection is of great importance in the process of learning and remembering what has been learnt. These is a parallel change in the structural and functional characteristics of the synaptic junctions during the learning process. The exact molecular mechanism behind this modification has been largely unknown until now.

Michael Kiebler and his colleagues have now identified a protein called, Staufen2, found to play a significant role in the mainatenance of synaptic junctions. A cell devoid of this protein would lose a significant proportion of the synapses. Associated impairment in other contact sites and the signalling mechanism have also been identified.

The protein is known to be invloved in the transport of mRNAs to to specific locations inside a cell. This has been found to largely dependent on the recognition of the mRNA by special RNA binding proteins and the subsequent transport to synaptic junctions. As any defect in this process (due to missing Staufen2 protein) has been found to result in structural and functional inhibition of the synapse, it is logical to assume that the protein also plays a major role in the process of learning and memory retention.

This finding has obviously led to a better understanding of the molecular mechanisms behind the ability of the brain to learn and remember. If in the future, such mechanisms can be manipulated, it could lead to a revolution. Somebody who has a poor learning capacity can be substituted with an ‘ideal brain’. This could go a long way in the treatment of disorders related to learning and memory function.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... Washington, DC (PRWEB) , ... May 06, 2016 ... ... Blum, Executive Vice President at CareFirst Blue Cross BlueShield and Former Principal Deputy ... Officer at CareMore - an Anthem Company; Steve Ondra, MD, Chief Medical Officer ...
(Date:5/5/2016)... Seattle, WA (PRWEB) , ... May 05, 2016 ... ... one ranking for overall select performance in the industry’s gold standard KLAS ... Expertise? The Epic Consulting report assessed organizations that specialize in consulting services ...
(Date:5/5/2016)... ... 05, 2016 , ... The U.S. Food and Drug Administration ... to submit their products through an arduous federal approval process. The rules, which ... the market since February 15, 2007. That would essentially ban 99 percent of ...
(Date:5/5/2016)... , ... May 05, 2016 , ... TLC Laser Eye ... Diego, California. The laser eye center will now be called “Gordon Schanzlin New Vision ... staff will remain at the full-service facility to ensure that patients continue to receive ...
(Date:5/5/2016)... Kansas (PRWEB) , ... May 05, 2016 , ... ... that some macroalgae can use ultraviolet light A (UV-A) for photosynthesis, researchers Juntian ... of red, green, and brown seaweeds. The pair observed that when photosynthetically active ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research ... the  "Europe Thrombocythemia Market and Competitive ... their offering.       (Logo: ... latest research Europe Thrombocythemia Market and ... comprehensive insights into Thrombocythemia pipeline products, ...
(Date:5/4/2016)... Diversified Holdings (NYSE: CODI ) ("CODI," "we," ... market businesses, announced today its consolidated operating results for ... First Quarter 2016 Highlights , Generated Cash Flow ... of $13.6 million for the first quarter of 2016; ... the first quarter of 2016; , Paid a ...
(Date:5/4/2016)... According to market research "Global Computed ... to 2022 - Industry Insights by Slice Type (High, Mid ... by P&S Market Research, the global computed tomography market ... is expected to grow at a CAGR of 5.0% during ... is expected to witness the faster growth, CAGR of 5.3%, ...
Breaking Medicine Technology: